Shots:

• The Japan Ministry of Health- Labor and Welfare approves the evaluation of iPS cells in a clinical research for spinal cord injuries at Keio University in Tokyo- with expected onset in H1’2019
• The study is will be conducted enrolling 4 adults with spinal cord injuries whose sensation and bodily mobility have been completely lost- transplating 2M cells of iPS with the usage of immunosuppressant drugs to control transplant rejection
• iPSCs are adult cells genetically reprogrammed to an embryonic stem cell for expressing genes & properties of embryonic stem cell. In 2014 & 2018- RIKEN Center for Developmental Biology & Kyoto University initiated trials using iPSCs for treat eye disorder & Parkinson’s disease respectively

Ref: Reuters | Image: Getty Images